Specialty Pharma Journal Specialty, Precision & Technology

Today, Kite Pharma, Inc. announced that it has expanded its immuno-oncology partnership with Tel Aviv …

Long-term use of contraceptive pills may double the risk of developing brain cancer, according to …

Indian generic drugmaker Strides Arcolab recently announced that it has entered a licensing deal to …

The US Food and Drug Administration (FDA) and the European Commission (EC) approved Novartis’ biologic …

During the State of the Union address, President Barack Obama announced his new “Precision Medicine” …

Not every form of cancer can be cured. Sometimes the best outcome is living with …

Marathon Pharmaceuticals’ investigational Duchenne Muscular Dystrophy (DMD) drug was granted Fast Track designation by US …

Last week, a bill was re-introduced in the Colorado Senate, which would allow pharmacists to …

Today, CytRx Corporation announced that US health regulators removed a partial clinical hold on its …

San Diego-based Neurocrine Biosciences, Inc. announced that the US Food and Drug Administration (FDA) has …

European regulators have approved AbbVie’s all-oral, interferon-free hepatitis C drug. The company announced today that …

Swiss drugmaker Roche has signed an agreement to acquire privately-held Trophos for up to $545 …

While patients with metastatic colorectal cancer are undergoing less surgery for the removal of their …

Health care giant Johnson & Johnson (J&J) is the first device-maker to agree to broadly …

Consider these two facts: Chronic infection with the hepatitis C virus (HCV) is a life-threatening …